1. Home
  2. HURC vs PRQR Comparison

HURC vs PRQR Comparison

Compare HURC & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HURC

Hurco Companies Inc.

HOLD

Current Price

$22.60

Market Cap

139.9M

Sector

Industrials

ML Signal

HOLD

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

HOLD

Current Price

$1.80

Market Cap

166.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HURC
PRQR
Founded
1968
2012
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
139.9M
166.5M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
HURC
PRQR
Price
$22.60
$1.80
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.25
AVG Volume (30 Days)
44.6K
1.3M
Earning Date
06-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
8.59
N/A
EPS
N/A
N/A
Revenue
$178,554,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$13.92
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.50
$1.33
52 Week High
$23.75
$3.10

Technical Indicators

Market Signals
Indicator
HURC
PRQR
Relative Strength Index (RSI) 71.11 56.15
Support Level $16.51 $1.39
Resistance Level $23.75 $2.05
Average True Range (ATR) 0.80 0.19
MACD -0.09 0.02
Stochastic Oscillator 57.63 70.63

Price Performance

Historical Comparison
HURC
PRQR

About HURC Hurco Companies Inc.

Hurco Companies Inc is an international industrial technology company that designs, manufactures, and sells computerized (CNC) machine tools for the metal cutting industry through a international sales and distribution network. Its proprietary control systems and software are sold as integral components of its machine tools. The Company also provides machine tool components, automation solutions, software options, upgrades, accessories, replacement parts, and related support services. It operates in the Americas, Europe, and Asia Pacific, with the Americas contributing the majority of revenue. Its core products include vertical and horizontal machining centers (mills), turning centers (lathes), and toolroom machines.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.

Share on Social Networks: